228 related articles for article (PubMed ID: 19885835)
1. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma.
McWilliams RR; Petersen GM; Rabe KG; Holtegaard LM; Lynch PJ; Bishop MD; Highsmith WE
Cancer; 2010 Jan; 116(1):203-9. PubMed ID: 19885835
[TBL] [Abstract][Full Text] [Related]
2. Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls.
Weiss FU; Simon P; Bogdanova N; Mayerle J; Dworniczak B; Horst J; Lerch MM
Gut; 2005 Oct; 54(10):1456-60. PubMed ID: 15987793
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.
Malats N; Casals T; Porta M; Guarner L; Estivill X; Real FX
Gut; 2001 Jan; 48(1):70-4. PubMed ID: 11115825
[TBL] [Abstract][Full Text] [Related]
4. Clinical and morphological characteristics of sporadic genetically determined pancreatitis as compared to idiopathic pancreatitis: higher risk of pancreatic cancer in CFTR variants.
Hamoir C; Pepermans X; Piessevaux H; Jouret-Mourin A; Weynand B; Habyalimana JB; Leal T; Geubel A; Gigot JF; Deprez PH
Digestion; 2013; 87(4):229-39. PubMed ID: 23751316
[TBL] [Abstract][Full Text] [Related]
5. Subject review: pancreatic ductal adenocarcinoma in the setting of mutations in the cystic fibrosis transmembrane conductance regulator gene: case report and review of the literature.
Rittenhouse DW; Talbott VA; Anklesaria Z; Brody JR; Witkiewicz AK; Yeo CJ
J Gastrointest Surg; 2011 Dec; 15(12):2284-90. PubMed ID: 21809164
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer.
Matsubayashi H; Fukushima N; Sato N; Brune K; Canto M; Yeo CJ; Hruban RH; Kern SE; Goggins M
Cancer Biol Ther; 2003; 2(6):652-5. PubMed ID: 14688470
[TBL] [Abstract][Full Text] [Related]
7. CFTR, SPINK1, PRSS1, and CTRC mutations are not associated with pancreatic cancer in German patients.
Schubert S; Traub F; Brakensiek K; von Kopylow K; Marohn B; Maelzer M; Gaedcke J; Kreipe H; Stuhrmann M
Pancreas; 2014 Oct; 43(7):1078-82. PubMed ID: 25003218
[TBL] [Abstract][Full Text] [Related]
8. [CFTR F508DEL mutation and 5T allele in patients with chronic pancreatitis and pancreatic adenocarcinoma].
Nikolić A; Dinić J; Radojković D; Lukić S; Popović D; Ugljesić M; Knezević S
Acta Chir Iugosl; 2011; 58(3):43-7. PubMed ID: 22369017
[TBL] [Abstract][Full Text] [Related]
9. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
[TBL] [Abstract][Full Text] [Related]
10. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.
Sharer N; Schwarz M; Malone G; Howarth A; Painter J; Super M; Braganza J
N Engl J Med; 1998 Sep; 339(10):645-52. PubMed ID: 9725921
[TBL] [Abstract][Full Text] [Related]
12. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.
Cohn JA; Friedman KJ; Noone PG; Knowles MR; Silverman LM; Jowell PS
N Engl J Med; 1998 Sep; 339(10):653-8. PubMed ID: 9725922
[TBL] [Abstract][Full Text] [Related]
13. Risk of pancreatitis with mutation of the cystic fibrosis gene.
Choudari CP; Imperiale TF; Sherman S; Fogel E; Lehman GA
Am J Gastroenterol; 2004 Jul; 99(7):1358-63. PubMed ID: 15233679
[TBL] [Abstract][Full Text] [Related]
14. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.
Ooi CY; Durie PR
J Cyst Fibros; 2012 Sep; 11(5):355-62. PubMed ID: 22658665
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the CFTR gene in pancreatic disease.
Pezzilli R; Morselli-Labate AM; Mantovani V; Romboli E; Selva P; Migliori M; Corinaldesi R; Gullo L
Pancreas; 2003 Nov; 27(4):332-6. PubMed ID: 14576497
[TBL] [Abstract][Full Text] [Related]
17. Female cystic fibrosis mutation carriers and assisted reproductive technology: does carrier status affect reproductive outcomes?
VanWort TA; Lee JA; Karvir H; Whitehouse MC; Beim PY; Copperman AB
Fertil Steril; 2014 Nov; 102(5):1324-30. PubMed ID: 25217870
[TBL] [Abstract][Full Text] [Related]
18. Acute Recurrent and Chronic Pancreatitis as Initial Manifestations of Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Disorders.
Baldwin C; Zerofsky M; Sathe M; Troendle DM; Perito ER
Pancreas; 2019 Aug; 48(7):888-893. PubMed ID: 31268981
[TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma.
McWilliams R; Highsmith WE; Rabe KG; de Andrade M; Tordsen LA; Holtegaard LM; Petersen GM
Gut; 2005 Nov; 54(11):1661-2. PubMed ID: 16227367
[No Abstract] [Full Text] [Related]
20. Secondhand Smoke Exposure and Serum Trypsinogen in Cystic Fibrosis Carriers.
Ellery KM; Kopp B; Conwell DL; Gariepy C
Pancreas; 2019 Oct; 48(9):1155-1159. PubMed ID: 31593019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
